Researchers from Nitrase Therapeutics Inc. recently presented preclinical findings on NTX-101, a murine chimeric antibody designed to specifically bind to nitrated tyrosine on α-synuclein (α-Syn). It ...
We then evaluated each contender on a number of key factors, including originality, efficacy, ambition, and impact. The result is a list of 200 groundbreaking inventions (and 50 special mention ...
The exploratory analysis of patients with MIBC also showed continued efficacy benefits, irrespective of PD-L1 status. No new safety signals were reported. Overall, these results further support ...